RE:RE:RE:RE:RE:ADCOM lineRed
My expectation is that the actual cost of producing
MCNA will be less than what it cost to produce BCG as it is a
safer drug with the expectation of lower side bar issues.
My off the cuff guess is probably 10% of what we sell it for but
the selling marketing and distribution fees will be pretty steep
in the beginning but our milestone payments will kick in to reduce
the hit. Here is to getting a deal for Japan and a few more million.
If those waiting in the wings don't do a deal before an FDA yes
the asking price for Japan will be a lot more.
HT